17-43074658-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_007294.4(BRCA1):​c.4485-137T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.386 in 775,348 control chromosomes in the GnomAD database, including 62,443 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★).

Frequency

Genomes: 𝑓 0.45 ( 17307 hom., cov: 31)
Exomes 𝑓: 0.37 ( 45136 hom. )

Consequence

BRCA1
NM_007294.4 intron

Scores

2

Clinical Significance

Benign reviewed by expert panel B:5

Conservation

PhyloP100: -0.576

Publications

15 publications found
Variant links:
Genes affected
BRCA1 (HGNC:1100): (BRCA1 DNA repair associated) This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020]
BRCA1 Gene-Disease associations (from GenCC):
  • BRCA1-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast-ovarian cancer, familial, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Fanconi anemia, complementation group S
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • pancreatic cancer, susceptibility to, 4
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 17-43074658-A-T is Benign according to our data. Variant chr17-43074658-A-T is described in ClinVar as Benign. ClinVar VariationId is 209375.Status of the report is reviewed_by_expert_panel, 3 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.682 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_007294.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA1
NM_007294.4
MANE Select
c.4485-137T>A
intron
N/ANP_009225.1P38398-1
BRCA1
NM_001407581.1
c.4551-137T>A
intron
N/ANP_001394510.1A0A2R8Y7V5
BRCA1
NM_001407582.1
c.4551-137T>A
intron
N/ANP_001394511.1A0A2R8Y7V5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA1
ENST00000357654.9
TSL:1 MANE Select
c.4485-137T>A
intron
N/AENSP00000350283.3P38398-1
BRCA1
ENST00000471181.7
TSL:1
c.4548-137T>A
intron
N/AENSP00000418960.2P38398-7
BRCA1
ENST00000470026.6
TSL:1
c.4485-137T>A
intron
N/AENSP00000419274.2P38398-1

Frequencies

GnomAD3 genomes
AF:
0.451
AC:
68553
AN:
151870
Hom.:
17260
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.688
Gnomad AMI
AF:
0.284
Gnomad AMR
AF:
0.376
Gnomad ASJ
AF:
0.364
Gnomad EAS
AF:
0.371
Gnomad SAS
AF:
0.522
Gnomad FIN
AF:
0.404
Gnomad MID
AF:
0.424
Gnomad NFE
AF:
0.340
Gnomad OTH
AF:
0.426
GnomAD4 exome
AF:
0.370
AC:
230913
AN:
623360
Hom.:
45136
AF XY:
0.376
AC XY:
124821
AN XY:
331682
show subpopulations
African (AFR)
AF:
0.682
AC:
10996
AN:
16126
American (AMR)
AF:
0.352
AC:
11211
AN:
31816
Ashkenazi Jewish (ASJ)
AF:
0.372
AC:
7140
AN:
19190
East Asian (EAS)
AF:
0.351
AC:
11339
AN:
32294
South Asian (SAS)
AF:
0.527
AC:
31692
AN:
60182
European-Finnish (FIN)
AF:
0.395
AC:
13117
AN:
33242
Middle Eastern (MID)
AF:
0.430
AC:
1070
AN:
2490
European-Non Finnish (NFE)
AF:
0.333
AC:
131928
AN:
395630
Other (OTH)
AF:
0.383
AC:
12420
AN:
32390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
7290
14580
21870
29160
36450
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1860
3720
5580
7440
9300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.452
AC:
68657
AN:
151988
Hom.:
17307
Cov.:
31
AF XY:
0.454
AC XY:
33704
AN XY:
74290
show subpopulations
African (AFR)
AF:
0.688
AC:
28544
AN:
41464
American (AMR)
AF:
0.376
AC:
5743
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.364
AC:
1264
AN:
3470
East Asian (EAS)
AF:
0.370
AC:
1913
AN:
5170
South Asian (SAS)
AF:
0.521
AC:
2509
AN:
4818
European-Finnish (FIN)
AF:
0.404
AC:
4258
AN:
10528
Middle Eastern (MID)
AF:
0.418
AC:
123
AN:
294
European-Non Finnish (NFE)
AF:
0.340
AC:
23141
AN:
67968
Other (OTH)
AF:
0.429
AC:
904
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1760
3520
5280
7040
8800
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
622
1244
1866
2488
3110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.400
Hom.:
1651
Bravo
AF:
0.455
Asia WGS
AF:
0.466
AC:
1621
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
1
Breast-ovarian cancer, familial, susceptibility to, 1 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.078
DANN
Benign
0.66
PhyloP100
-0.58
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2236762; hg19: chr17-41226675; COSMIC: COSV58801011; API